Vigantoletten



Indications and Reactions:

Role Indications Reactions
Secondary
Chronic Obstructive Pulmonary Disease 22.2%
Osteoporosis 7.7%
Product Used For Unknown Indication 7.7%
Sedation 7.7%
Cardiac Disorder 6.8%
Hypertension 6.0%
Alcohol Withdrawal Syndrome 5.1%
Coronary Artery Disease 5.1%
Atrial Fibrillation 4.3%
Prophylaxis 4.3%
Mucous Membrane Disorder 3.4%
Tachyarrhythmia 3.4%
Arthritis 2.6%
Dyspnoea 2.6%
Hypokalaemia 2.6%
Blood Glucose 1.7%
Diabetes Mellitus 1.7%
Evidence Based Treatment 1.7%
Fluid Replacement 1.7%
Infection 1.7%
Toxic Epidermal Necrolysis 57.1%
Flank Pain 14.3%
Stridor 14.3%
Suicide Attempt 14.3%
Concomitant
Product Used For Unknown Indication 25.0%
Rheumatoid Arthritis 17.8%
Osteoporosis 10.5%
Hypertension 9.6%
Drug Use For Unknown Indication 8.4%
Pain 5.1%
Coronary Artery Disease 2.8%
Constipation 2.0%
Prophylaxis Against Transplant Rejection 2.0%
Prophylaxis 1.9%
Epilepsy 1.8%
Renal Transplant 1.8%
Osteoporosis Prophylaxis 1.7%
Parkinson's Disease 1.7%
Bladder Disorder 1.7%
Crohn's Disease 1.6%
Convulsion 1.2%
Depression 1.2%
Polyarthritis 1.1%
Sleep Disorder 1.1%
Vomiting 10.6%
Progressive Multifocal Leukoencephalopathy 8.7%
White Blood Cell Count Decreased 8.7%
Urinary Tract Infection 7.7%
Pain In Extremity 5.8%
Pyrexia 5.8%
Sepsis 5.8%
Tachycardia 4.8%
Transplant Rejection 4.8%
Weight Decreased 4.8%
Hypertension 3.8%
Intervertebral Disc Protrusion 3.8%
Psychotic Disorder 3.8%
Ureteral Stent Removal 3.8%
Convulsion 2.9%
Cytomegalovirus Infection 2.9%
Drug Interaction 2.9%
Kidney Transplant Rejection 2.9%
Nail Discolouration 2.9%
Rash 2.9%
Interacting
Drug Use For Unknown Indication 38.5%
Product Used For Unknown Indication 15.4%
Dementia Alzheimer's Type 7.7%
Epilepsy 7.7%
Gastritis 7.7%
Hyperthyroidism 7.7%
Osteoporosis 7.7%
Parkinson's Disease 7.7%
Drug Interaction 50.0%
Restlessness 50.0%